NCT01988974

Brief Summary

The purpose of this study is to determine the psychometric properties of the Knowledge, Attitudes, and Beliefs about Atrial Fibrillation Survey (KABAFS) and to generate critical, practical knowledge about the feasibility of conducting a randomized trial to test the effect of the Alert for Atrial Fibrillation program on treatment-seeking for symptoms of Atrial Fibrillation (AF).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P25-P50 for not_applicable atrial-fibrillation

Timeline
Completed

Started Nov 2013

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2013

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

November 14, 2013

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 20, 2013

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2015

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2015

Completed
Last Updated

March 24, 2017

Status Verified

March 1, 2017

Enrollment Period

1.7 years

First QC Date

November 14, 2013

Last Update Submit

March 22, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Changes on the Knowledge, Attitudes, and Beliefs about Atrial Fibrillation Survey

    The KABAFS assesses patient knowledge of Atrial Fibrillation (AF) and the belief factors associated with delay in seeking treatment for AF. Participants will be measured at baseline (before the intervention), and then at 1 and 2 months after the intervention to identify if participants' knowledge and beliefs about treatment seeking have improved and continue to be improved from baseline as indicated by the KABAFS score.

    Baseline, One Month, Two Months

Study Arms (2)

Alert for AF Program

EXPERIMENTAL

1\) participation in the Alert for Atrial Fibrillation program ) .

Behavioral: Alert for Atrial Fibrillation Program

Attention control condition

ACTIVE COMPARATOR

2\) participation in the healthy sleep program

Behavioral: Healthy Sleep

Interventions

Participants' baseline knowledge of AF symptoms, and attitudes and beliefs about AF will be assessed using the KABAFS, and patients will receive cognitive-behavioral training directed toward survey responses associated with delay of treatment. Training will incorporate the content developed by the American College of Cardiology Foundation (ACCF), and participants will receive education about how to recognize an irregular pulse, and how to record the pulse rhythm in a daily log. The PI/RN coordinator will review the completed KABAFS to assess knowledge deficits, and identify attitudes and beliefs about AF that may hinder early treatment-seeking.

Alert for AF Program
Healthy SleepBEHAVIORAL

Participants will receive a 45 minute face to face instruction about sleep hygiene

Attention control condition

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • years of age or older
  • Under the care of providers from the Department of Medicine
  • English-speaking
  • Community dwelling,
  • Have access to and ability to communicate via a telephone
  • Have one or more risks for developing AF
  • Not be diagnosed with AF

You may not qualify if:

  • Documented cognitive impairment
  • Uncompensated hearing or visual deficits
  • Scheduled for surgery or have undergone a surgical procedure in the last 30 days,
  • Undergoing active treatment for a malignancy
  • Receiving hospice care will be excluded

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic

Rochester, Minnesota, 55905, United States

Location

MeSH Terms

Conditions

Atrial Fibrillation

Interventions

Caffeine

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

XanthinesAlkaloidsHeterocyclic CompoundsPurinonesPurinesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-Ring

Study Officials

  • Pamela J McCabe, PhD, RN

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Nursing

Study Record Dates

First Submitted

November 14, 2013

First Posted

November 20, 2013

Study Start

November 1, 2013

Primary Completion

July 1, 2015

Study Completion

September 1, 2015

Last Updated

March 24, 2017

Record last verified: 2017-03

Data Sharing

IPD Sharing
Will not share

Locations